Select your country

North & South America

North & South America

Argentina

Local distributor

Argentina

JUSTESA IMAGEN ARGENTINA, S.A.

Viamonte 1328, 9º piso
1053 Buenos Aires
(Capital Federal)

ph. +5411 4373-0629
Canada
EN | FR
Colombia

Local distributor

Colombia

Sistemas Medicos, LTDA.

Apartado Aereo 24456
Calle 58 No. 35A61
Bogota
(Colombia)

ph. +571-221-9837
Fax +571-222-5310
Perù

Local distributor

Perù

REIMED, SCRL

Pasaje Villaran 192-194 U-12
Urb. Los Sauces Surquillo
Lima 15076
(Peru)

ph. 511-448-1087
Fax 511-448-3447
Uruguay

Local distributor

Uruguay

Lifenir S.A.

Justicia 2069
C 11800 Montevideo
(Uruguay)

ph. +5982-400-3020
Fax +5982-4007320
Venezuela

Local distributor

Venezuela

SUFOMECA

Torre Polar Oeste
Plaza Venezuela
Floor 7, Room 7C
Caracas
PO Box 1050
(Venezuela)

ph. +582-12-793-3222
Fax +582-12-781-1923

Europe

Europa

Bosnia-Herzegowina

Local distributor

Bosnia-Herzegowina

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Bulgaria

Local distributor

Bulgaria

EWOPHARMA AG

73 Persenk Street
App. 27 - Floor 8
1164 Sofia
(Bulgaria)

ph. +359 29624478
Fax +359 28683968
Croatia

Local distributor

Croatia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Greece

Local distributor

Greece

LERIVA IMAGING S.A.

33 Pigis Avenue &
6 Anapiron Polemou Street
151 27 Melissia
Athens (Greece)

ph. +30 210-6199886
Fax +30 210 61 78 733
Montenegro

Local distributor

Montenegro

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Romania

Local distributor

Romania

EWOPHARMA A.G. ROMANIA

B-dul Primaverii 19 -21
Sc. B - Et.1 - Sect. 1
011972 - Bucharest
(Romania)

ph. +40 212601344
Fax +40 212029327
Serbia

Local distributor

Serbia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Slovenia

Local distributor

Slovenia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Hungary

Local distributor

Ungheria

EWOPHARMA REPRESENTATION OFFICE

Budakeszi ut 73/F
H-1021 Budapest
(Hungary)

ph. +36 12004650
Fax +36 13980316

Eastern Europe, Middle East & Africa

Eastern Europe, Middle East & Africa

Ethiopia

Local distributor

Ethiopia

Caroga Pharma PVT. Ltd

P.O.Box 12627
Addis Abeba
(Ethiopia)

ph. +251 11 4654944 / 11 4161090
Fax +251 11 4654595
Ghana

Local distributor

Ghana

Cyndex Pharmacy

P.O.Box DS 1165 Dansoman
Accra
(Ghana)

ph. +233 21553370
Fax +233-244366622 / 21850072
Israel

Local distributor

Israel

DEXCEL

Or-Akiva 30600
30600000 Israel
(Israel)

ph. +972-4-6364015
Fax +972-4-6364004
Jordan

Local distributor

Jordan

THE ARAB DRUG STORE

Khaleel Al Salem street
Amman
(Jordan)

ph. +962 6 5502995
Fax +962 6 5502984
Kenya

Local distributor

Kenya

Nairobi X-Rays Supplies Ltd.

P.O. Box 41669
Nairobi
(Kenya)

ph. +254 20446265-6-7-8
Fax +254 20 4448515/17
Lebanon

Local distributor

Lebanon

Unione Pharmaceutic. d'Orient

Rue du Musée Imm. Stephan QtrBadaro
Beyrouth
(Lebanon)

ph. +961 1 396085-6
Fax +961 1 396047
Mauritius

Local distributor

Mauritius

The Mauritius Pharmacy

4, Louis Pasteur Str Forest Side
(Mauritius)

ph. +230 6762435
Fax +230 675 1387
Saudi Arabia

Local distributor

Saudi Arabia

SARABEEL COMMERCIAL EST.

Medical Division
P.O. BOX 14795
21434 Jeddah
(Saudi Arabia)

ph. +966 12657 2246
South Africa

Local distributor

South Africa

AXIM - Head Office Midrand

121 Gazelle Avenue
Corporate Park South
Midrand Johannesburg 2000
(South Africa)

ph. +27 113140140
Fax +27 113140141
Uganda

Local distributor

Uganda

Kampala X-Rays Suppliers

Plot 181 Bombo Rd (KuBbiri)
P.O. Box 9519
Kampala
(Uganda)

ph. +256 41 534313
Fax +256 41 349919
Ukraine

Local distributor

Ukraine

DELTA MEDlCAL

43 Chernovola
Vishnevoe - 08132
(Ukraine)

ph. +38 445933355
United Arab Emirates

Local distributor

United Arab Emirates

MANARA HEALTHCARE

Concord Tower, 6th Floor
Dubai Media City
PO Box 213593, Dubai
United Arab Emirates

 

ph. +971 4 454 9712
Fax 971 4 454 2310

Asia Pacific

Asia Pacific

Australia

Local distributor

Australia

REGIONAL HEALTH CARE GROUP

3-11 Primrose Avenue Rosebery
NSW 2018 - Sydney
(Australia)

ph. +61 296624144
Fax +61 296626040
India

Local distributor

India

Imaging Products (India ) Ltd

Mumbai
(India)

ph. +91 9819725471
Fax +91 2228320208
Indonesia

Local distributor

Indonesia

PT DIPA PHARMALAB INTERSAINS

Jl. Panjang No. 10
Kebon Jeruk
Jakarta 11530
(Indonesia)

ph.  +62 215348644
Fax +62 2153676066
New Zealand

Local distributor

New Zealand

REGIONAL HEALTH LIMITED

19C Orbit Drive
Mairangi Bay
(New Zealand)

ph. +64 94140040
Fax +64 94140041
Pakistan

Local distributor

Pakistan

S. EJAZUDDIN & CO LTD

PO Box 5629 - Zia Plaza
Altaf Hussain Road
74000 Karachi
(Pakistan)

ph. +92 21212032
Fax +92 212629716
Philippines

Local distributor

Philippines

NEW MARKETLINK INTERNATIONAL CORP

Tao Corporate Centre 2291
Don Chino Roches Ave
Ext Makati City Metro
Manila (Philippines)

ph. (632) 836-5838
Singapore

Local distributor

Singapore

LF ASIA PHARMACEUTICAL DIVISION

Healthcare Distribution Centre
24 Penjuru Road (off Penjuru Close)
#03-04 CWT Commodity Hub
(Singapore 609128)

ph. +65 65097629
Taiwan

Local distributor

Taiwan

SUPER FORTUNE ENTERPRISE CO LTD

5 F-1 - 42 Sec.1 Ming
Sheng E. Road Jehovah Building
101 Taipei
(Taiwan)

ph. +886 225673456
Fax +886 225319231
Thailand

Local distributor

Thailand

Interpharmacare Co., Ltd.

90 Moo 13 Soi Mahacha
Bangpleeyai
Bangplee
Samutprakarn 10540
(Thailand)

ph. + 66 2 675 9140-2
Fax + 66 2 325 0265
Vietnam

Local distributor

Vietnam

HOANG GIA INVESCO, JSC

No 74-76 Hoa Bang Str
Cau Giay
Dist Ha Noi Hanoi
(Viet Nam)

ph. +43 7846952
 

Select your country

Asia

Australia

Local distributor

Australia

REGIONAL HEALTH CARE GROUP

3-11 Primrose Avenue Rosebery
NSW 2018 - Sydney
(Australia)

ph. +61 296624144
Fax +61 296626040
India

Local distributor

India

Imaging Products (India ) Ltd

Mumbai
(India)

ph. +91 9819725471
Fax +91 2228320208
Indonesia

Local distributor

Indonesia

PT DIPA PHARMALAB INTERSAINS

Jl. Panjang No. 10
Kebon Jeruk
Jakarta 11530
(Indonesia)

ph.  +62 215348644
Fax +62 2153676066
New Zealand

Local distributor

New Zealand

REGIONAL HEALTH LIMITED

19C Orbit Drive
Mairangi Bay
(New Zealand)

ph. +64 94140040
Fax +64 94140041
Pakistan

Local distributor

Pakistan

S. EJAZUDDIN & CO LTD

PO Box 5629 - Zia Plaza
Altaf Hussain Road
74000 Karachi
(Pakistan)

ph. +92 21212032
Fax +92 212629716
Philippines

Local distributor

Philippines

NEW MARKETLINK INTERNATIONAL CORP

Tao Corporate Centre 2291
Don Chino Roches Ave
Ext Makati City Metro
Manila (Philippines)

ph. (632) 836-5838
Singapore

Local distributor

Singapore

LF ASIA PHARMACEUTICAL DIVISION

Healthcare Distribution Centre
24 Penjuru Road (off Penjuru Close)
#03-04 CWT Commodity Hub
(Singapore 609128)

ph. +65 65097629
Taiwan

Local distributor

Taiwan

SUPER FORTUNE ENTERPRISE CO LTD

5 F-1 - 42 Sec.1 Ming
Sheng E. Road Jehovah Building
101 Taipei
(Taiwan)

ph. +886 225673456
Fax +886 225319231
Thailand

Local distributor

Thailand

Interpharmacare Co., Ltd.

90 Moo 13 Soi Mahacha
Bangpleeyai
Bangplee
Samutprakarn 10540
(Thailand)

ph. + 66 2 675 9140-2
Fax + 66 2 325 0265
Vietnam

Local distributor

Vietnam

HOANG GIA INVESCO, JSC

No 74-76 Hoa Bang Str
Cau Giay
Dist Ha Noi Hanoi
(Viet Nam)

ph. +43 7846952

North & South America

Argentina

Local distributor

Argentina

JUSTESA IMAGEN ARGENTINA, S.A.

Viamonte 1328, 9º piso
1053 Buenos Aires
(Capital Federal)

ph. +5411 4373-0629
Colombia

Local distributor

Colombia

Sistemas Medicos, LTDA.

Apartado Aereo 24456
Calle 58 No. 35A61
Bogota
(Colombia)

ph. +571-221-9837
Fax +571-222-5310
Perù

Local distributor

Perù

REIMED, SCRL

Pasaje Villaran 192-194 U-12
Urb. Los Sauces Surquillo
Lima 15076
(Peru)

ph. 511-448-1087
Fax 511-448-3447
Uruguay

Local distributor

Uruguay

Lifenir S.A.

Justicia 2069
C 11800 Montevideo
(Uruguay)

ph. +5982-400-3020
Fax +5982-4007320
Venezuela

Local distributor

Venezuela

SUFOMECA

Torre Polar Oeste
Plaza Venezuela
Floor 7, Room 7C
Caracas
PO Box 1050
(Venezuela)

ph. +582-12-793-3222
Fax +582-12-781-1923

Europe

Bosnia-Herzegowina

Local distributor

Bosnia-Herzegowina

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Bulgaria

Local distributor

Bulgaria

EWOPHARMA AG

73 Persenk Street
App. 27 - Floor 8
1164 Sofia
(Bulgaria)

ph. +359 29624478
Fax +359 28683968
Croatia

Local distributor

Croatia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Greece

Local distributor

Greece

LERIVA IMAGING S.A.

33 Pigis Avenue &
6 Anapiron Polemou Street
151 27 Melissia
Athens (Greece)

ph. +30 210-6199886
Fax +30 210 61 78 733
Montenegro

Local distributor

Montenegro

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Romania

Local distributor

Romania

EWOPHARMA A.G. ROMANIA

B-dul Primaverii 19 -21
Sc. B - Et.1 - Sect. 1
011972 - Bucharest
(Romania)

ph. +40 212601344
Fax +40 212029327
Serbia

Local distributor

Serbia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Slovenia

Local distributor

Slovenia

MARK Srl

Via S. Michele 334
34170 Gorizia
(Italy)

Montenegro

ph. +39 481217111
Fax +39 48120719
Ungheria

Local distributor

Ungheria

EWOPHARMA REPRESENTATION OFFICE

Budakeszi ut 73/F
H-1021 Budapest
(Hungary)

ph. +36 12004650
Fax +36 13980316

Eastern Europe, Middle East & Africa

Ethiopia

Local distributor

Ethiopia

Caroga Pharma PVT. Ltd

P.O.Box 12627
Addis Abeba
(Ethiopia)

ph. +251 11 4654944 / 11 4161090
Fax +251 11 4654595
Ghana

Local distributor

Ghana

Cyndex Pharmacy

P.O.Box DS 1165 Dansoman
Accra
(Ghana)

ph. +233 21553370
Fax +233-244366622 / 21850072
Israel

Local distributor

Israel

DEXCEL

Or-Akiva 30600
30600000 Israel
(Israel)

ph. +972-4-6364015
Fax +972-4-6364004
Jordan

Local distributor

Jordan

THE ARAB DRUG STORE

Khaleel Al Salem street
Amman
(Jordan)

ph. +962 6 5502995
Fax +962 6 5502984
Kenya

Local distributor

Kenya

Nairobi X-Rays Supplies Ltd.

P.O. Box 41669
Nairobi
(Kenya)

ph. +254 20446265-6-7-8
Fax +254 20 4448515/17
Lebanon

Local distributor

Lebanon

Unione Pharmaceutic. d'Orient

Rue du Musée Imm. Stephan QtrBadaro
Beyrouth
(Lebanon)

ph. +961 1 396085-6
Fax +961 1 396047
Mauritius

Local distributor

Mauritius

The Mauritius Pharmacy

4, Louis Pasteur Str Forest Side
(Mauritius)

ph. +230 6762435
Fax +230 675 1387
Saudi Arabia

Local distributor

Saudi Arabia

SARABEEL COMMERCIAL EST.

Medical Division
P.O. BOX 14795
21434 Jeddah
(Saudi Arabia)

ph. +966 12657 2246
South Africa

Local distributor

South Africa

AXIM - Head Office Midrand

121 Gazelle Avenue
Corporate Park South
Midrand Johannesburg 2000
(South Africa)

ph. +27 113140140
Fax +27 113140141
Uganda

Local distributor

Uganda

Kampala X-Rays Suppliers

Plot 181 Bombo Rd (KuBbiri)
P.O. Box 9519
Kampala
(Uganda)

ph. +256 41 534313
Fax +256 41 349919
Ukraine

Local distributor

Ukraine

DELTA MEDlCAL

43 Chernovola
Vishnevoe - 08132
(Ukraine)

ph. +38 445933355

RESP product logo

Safety and Control. Improved Workflow. Touchscreen Technology.

The EmpowerCTA+ Injector System represents the ultimate in contrast injector technology, meeting the needs of today’s CT suites by facilitating high-quality CT imaging.

Thumbnails

EmpowerCTA®+ Injector System

accordion

The EmpowerCTA+ Injector System represents the ultimate in contrast injector technology, meeting the needs of today’s CT suites by facilitating high-quality CT imaging.

Unique safety enhancements combined with a digital touch screen at the patient’s side and voice prompts give EmpowerCTA+ Injector System users increased process control and a more streamlined workflow.

UNIQUE SAFETY ENHANCEMENTS

  • Saline advance: Delivered via pendant switch or key on the injector at the patient's side prior to starting the procedure, allows for the use of saline to test patency and vein integrity
  • Saline jump: Allows for the immediate advancement to saline (once opacification has been reached), minimizing the contrast a patient receives
  • Unique patented EDATM (extravasation detection accessory)* Detects, notifies, and pauses procedure if clinically significant variation occurs; detects extravasation with patented EDA patch, providing additional patient safety and peace of mind for the technologist
  • eGFR calculator: Assists in the critical evaluation of kidney function before contrast is delivered

STREAMLINED WORKFLOW

  • Simultaneously-operating dual syringes
  • Auto initialization: The most efficient way to prepare syringes for filling
  • Protocol fill: Automatically fills syringes to volumes based on the selected protocol

INTEGRATED EFFICIENCIES

  • Built-in tilt sensor and position lock to minimize the likelihood of an air embolism
  • Convenient remote control pause function
  • Fixed fill rate
  • Purge function to automatically remove air from the system

Utilize the EmpowerCTA+ Injector System, and the NEXO® Contrast Management System to build a complete imaging system that is more than the sum of its parts.

*EDA is designed to aid in the detection of extravasations and is not intended as a substitute for proper patient monitoring and good clinical practice.

EDA is a trademark of Bracco Injeneering S.A.

Product Product SKU Description
EmpowerCTA®+ Injector System 017383 Includes: Injector head, remote control (Windows®-based operating system), remote control desktop mount, power supply, and all cables and injector pendant switches.
Pedestal Mount 102372 Basic system with rolling floor stand
Ceiling Mount 102369 Basic system with overhead ceiling mount
Pedestal Mount with EDATM (Extravasation Detection Accessory)* 102365 Basic system with rolling floor stand, EDA module, EDA cable
Ceiling Mount with EDATM (Extravasation Detection Accessory)* 102362 Basic system with ceiling mount, EDA module, EDA cable
Disposables    
Bracco Injeneering (BINJ) Transfer Set 017349 (100) Sterile tubing set for connection between an ISOVUE® (Iopamidol Injection) Imaging Bulk Package and empty sterile syringes on single-use-only, syringe based contrast delivery systems (injectors). Approx. 20 inches long, and its components are made with medical grade materials.
FastLoadTM CTA Dual Syringe Pack with Spikes 17347 Tray includes (2) 200 mL disposable syringes with bifurcated dual check valve, (1) 60” low-pressure extension set, (1) large transfer spike for saline, and (1) small transfer spike for contrast.
FastLoadTM CT Syringe Pack with Spike 17345 Tray includes (1) 200 mL disposable syringe with (1) 60” low-pressure extension set and (1) small transfer spike for contrast

*EDA is designed to aid in the detection of extravasations and is not intended as a substitute for proper patient monitoring and good clinical practice.

EDA and FastLoad are trademarks of Bracco Injeneering S.A.

Windows is a registered trademark of Microsoft Corporation.

INCREASED PROTOCOL MANAGEMENT

Protocol fill:

  • Automatically fills syringes to volumes based on the selected protocol
  • Protocol storage up to 100
  • Ease of customizing, naming, and storing specific protocols

EPPTM EMPOWER PHASING PROTOCOL
The combination of EPP and the EmpowerCTA+ Injector System with dual syringes for contrast and saline chase work with your scanner to help maximize the quality of a cardiac CT study.

EmpowerSync®
EmpowerSync provides CiA 425 CANOpen technology that allows "plug-and-play" interoperability between contrast delivery systems, and CT scanners.

Please work with your local specialist for compatibility with your specific scanner.

EPP is a trademark of ACIST Medical Systems, Inc.
EmpowerSync is a registered trademark of Bracco Injeneering S.A.

See how the EmpowerCTA+ Injector System can help increase patient safety and streamline CT suite workflow.

Learn how the Bracco portfolio of contrast injectors and customer support can help you accelerate patient care.

Learn how the innovative features of the EmpowerCTA+ Injector System can benefit CT suite operations.

Syringe packs help reduce the time to load syringes and minimize the chance of contamination.

The unique, patented Extravasation Detection Accessory (EDATM) provides additional patient safety and peace of mind for the technologist.

EDA is a trademark of Bracco Injeneering S.A.

Product support that's unsurpassed

Each EmpowerCTA+ Injector System comes with a complete support system:

  • 24/7 technical support
  • Flexible, cost-effective warranty options
  • Locally-based technicians to provide on-site preventive maintenance, service, and repair

For more information and to schedule an appointment with one of our specialists, contact:

Ken Bodle, Manager, Device Operations
Phone: 760-881-0449
259 Prospect Plains Road, Bldg. H Monroe Township, NJ 08831 USA
Email: kenneth.bodle@diag.bracco.com

For U.S. Technical Service and Support call: 888-670-7701
Fax: 609-514-2448
Email: customer.support@acistmedical.com

This video (1:20) presents a real-world example of the value of a triphasic injection protocol using the EmpowerCTA Injector System for a patient with suspected arrhythmogenic right ventricular dysplasia (ARVD).

Case courtesy of Suhny Abbara, MD, Assistant Professor, Harvard Medical School, Director, Cardiovascular Imaging, Massachusetts General Hospital, Director of Education, Cardiac MR/PET/CT Program

These are representative images from referenced studies; individual results may vary.

This case illustrates optimal enhancement of the left cardiac chambers and the right atrium and ventricles utilizing a triphasic injection protocol for functional assessment. A nonionic contrast agent was injected into this patient suspected of having ARVD using the EmpowerCTA Injector System.

The rationale for the injection protocol, outlined in this table, is to have optimal arterial opacification and instead of a washed-out heart, to have contrast within the right heart. The reduced rate of the second phase allows mixing of the slower injected contrast with a relatively larger amount of nonenhanced venous blood return from the head and the contralateral upper extremity, thus avoiding excessive mixing artifact in the right heart.

Injection Protocol: Triphasic Injection
Phase Flow Rate Volume Time
Test Bolus 5 mL/sec 20 mL 4 sec
Contrast Phase 1 5 mL/sec 60 mL 12 sec
Contrast Phase 2 2 mL/sec 20 mL 10 sec
Saline Phase 3 5 mL/sec 20 mL 4 sec

This case illustrates optimal enhancement of the left cardiac chambers and the right atrium and ventricles. Functional images allowed for assessment of right ventricular function and ejection fraction.

Coronary CTA acquired with triphasic injection protocol demonstrates good opacification of the left and right ventricles and both atria with no significant mixing artifact in the right heart.

The color illustrations demonstrate frames from the CT right ventriculagram which allow appreciation of fine anatomic detail.

Results with the EmpowerCTA Injector System and Toshiba 320 slice CT scanner for cardiac and vascular CT examinations at Brigham and Women's Hospital

Case studies courtesy of Orla Buckley MD, Andetta Hunsaker MD and Frank Rybicki MD, Brigham and Women's Hospital, Applied Imaging Science Laboratory, Department of Radiology

These are representative images from referenced studies; individual results may vary.

For the past 5 years, Brigham and Women's, a teaching hospital of Harvard Medical School, has incorporated the EmpowerCTA Injector System for cardiac and vascular CT exams. This selection of cases demonstrates the high-quality imaging obtained with this injection system and media.

Case 1: Coronary CT angiography
A 42-year-old nonsmoking marathon runner was referred for coronary CT angiography after an exercise stress test demonstrated S-T segment depression in the inferolateral leads. A gated CT evaluation was performed following 0.4 mg sublingual nitroglycerin and 5 mg intravenous metropolol, followed by intravenous injection of nonionic contrast media. Optimal arterial opacification was achieved by triggering off the descending thoracic aorta with a threshold Hounsfield unit (HU) set at 180.

These multiplanar reformatted images show a short segment of noncalcified plaque, indicative of severe stenosis, in the proximal left anterior descending coronary artery––– a finding that was confirmed by conventional coronary angiography.

A short segment of noncalcified plaque associated with severe stenosis in the proximal LAD (arrow) is shown by multiplanar reformatted images.

Lesion in the proximal LAD (arrow) was confirmed by conventional coronary angioplasty

Case 2: CT pulmonary angiography
A 74-year-old man with post-hemorrhagic stroke developed pleuritic chest pain and dyspnea during rehabilitation. Although there was a high level of clinical concern for pulmonary embolism, anticoagulation was considered high risk in light of the patient's recent history.

Contrast-enhanced CT pulmonary angiography was performed using 75 mL of nonionic contrast media injected at an infusion rate of 4 mL/second via the EmpowerCTA Injector System. Bolus tracking was used, triggering off the pulmonary artery with a threshold Hounsfield unit set at 180.

The CT was negative for pulmonary embolism. No anticoagulation was required.

Axial maximum intensity processing (MIP) image from CT pulmonary angiography

Coronal MIP from CT pulmonary angiogram

Case 3: Evaluation of coronary bypass graft using wide area detector CT angiography
A 78-year-old man developed recurrent chest pain on exertion following multi-vessel coronary artery bypass grafting. CT angiography was performed with intravenous injection of 80 mL nonionic contrast media at 6 cc per second via the EmpowerCTA Injector System.

Bypass graft stenosis at the insertion of the saphenous vein graft to the right coronary artery was confirmed angiographically. Graft stenosis is visible near the right coronary artery-touchdown, as seen in this 3-D volume rendering of the aortic root, bypass grafts, and left ventricular wall and cavity.

3-D volume rendered image includes the aortic root, bypass grafts, and left ventricular wall and cavity. Graft stenosis is visible near RCA touchdown.

Case 4: Renal perfusion using wide-area detector CT
It is important to rule out renal perfusion defects in potential renal donors. Utilizing 100 mL of nonionic contrast media, infused at a rate of 3 mL per second via the EmpowerCTA Injector System, a renal perfusion study of a potential donor was performed.

This 3-D volume-rendered image showing one phase of the study demonstrates no perfusion defects.

Wide area detector CT image from renal perfusion study

Development of a CTA protocol that provides high-quality coronary images while ensuring patient safety: Experience with the EmpowerCTA Injector System at the El Paso Heart Center

Case study courtesy of Felipe Perez, RT(R) (CT) ARRT, BHA, MBA, Director of Clinical and Diagnostic Services, El Paso Heart Center, El Paso, TX

These are representative images from referenced studies; individual results may vary.

The El Paso Heart Center has been using the EmpowerCTA Injector System since 2005, performing approximately 25,000 procedures with the system. Coronary procedures account for about 65% of the workload. Normal protocol includes completing a CTA of the coronary arteries and obtaining a pulmonary embolism chest study. Initially, the protocol was aligned with standard practice of 5 mL/sec, for a total contrast volume of 100 mL. A gated coronary study immediately followed by a scan of the entire chest was done, with a desired result of obtaining contrast in the left heart and saline in the right heart. With the speed inherent in a 64-row detector scanner, the desired Hounsfield number was detected and the scan begun in rapid order.

As these resulting images demonstrate, contrast on both sides of the heart made visualization of the right coronary artery somewhat challenging

In order to obtain the desired results, the amount of contrast was reduced to 60 mL while keeping the saline injection unchanged. The images were excellent for the coronary CTA but evaluating for pulmonary embolism remained difficult because there was very little residual contrast in the pulmonary arteries.

The next step was to establish a second phase of contrast before the saline. The injection time was extended by reducing the second contrast phase flow rate to 3 mL per second and adding 5 additional mL. To utilize the total contrast injection time, breathing instructions were given as the patient was moved into the acquisition start point. Automated initiation of the scan based on the desired Hounsfield was eliminated and performed manually. The level of attenuation during low dose dynamic scan was observed and the scan triggered as it began to quickly increase to the desired Hounsfield.

Phase Flow Rate Volume Time
*LOCM 300 5.0 mL/sec 50 mL 10 seconds
*LOCM 300 3.0 mL/sec 15 mL 5 seconds
Saline 5.0 mL/sec 40 mL 8 seconds

This protocol provided excellent contrast enhancement in the coronary and pulmonary arteries, as seen in this whole chest image.

Whole chest image utilizing current protocol

During the protocol development, 3 contrast extravasations occurred. Each time, the Extravasation Detection Accessory (EDATM) extravasation detection technology† in the EmpowerCTA Injector System stopped the injection.

The EDA feature was particularly critical because some extravasations occurred later in the injection process. If a technologist is monitoring real-time images and there is contrast in the superior vena cava, an extravasation may be overlooked. By the time the contrast appears less bright, or the patient complains of symptoms, it is too late. The EDA extravasation detection technology helped reduce this risk.

EDA is a trademark of Bracco Injeneering S.A.

See how you and your CT suite can Be Empowered with one of the most technologically advanced contrast power injectors available: the EmpowerCTA Injector System.

Watch the entire video (12:11) or view each section separately to see how every aspect of the efficient and user-friendly EmpowerCTA Injector System advances safety, enhances ease of use, and increases throughput.

*These videos should not be used as a substitute for the owner’s manual. Please refer to the EmpowerCTA manual for complete operating instructions.

Video Chapters

Injector Setup

Even with its advanced components the EmpowerCTA Injector Setup (1:44) is extremely user friendly.

Injector Cycle

Setting up the EmpowerCTA Injector Cycle (0:41) is a simple and safe procedure.

Performance

See how the EmpowerCTA Injector Performance (1:49) in a real-world patient scenario reflects its ease of use.

Safety Features

Look at some of the unique Safety Features (1:25) built into the EmpowerCTA Injector System.

Streamline Workflow

Learn how using the EmpowerCTA Injector System can Streamline Workflow (1:12)

Image Quality

See how the EmpowerCTA Injector System is able to offer exceptional Image Quality (1:00).

Capture Connectivity

The EmpowerCTA Injector System includes an innovative data management system. See how its Capture Connectivity (3:20) can work to your advantage.

EmpowerCTA+ Injector System enables precise performance with digital touch screen technology at the injector head, a pendant switch for increased control at the patient's side, and EDATM (Extravasation Detection Accessory)* for added patient safety.

Mounts
The EmpowerCTA+ Injector System is available with a ceiling mount, including the basic system and overhead ceiling mount, or with a pedestal mount, including the basic system and rolling floor stand.

Syringe Packs
With spikes conveniently included, syringe packs help reduce the time to load syringes and minimizes the chance of contamination. Spikes work with all volumes of contrast and saline, and allow you to choose the best set-up for patients and procedures. Download the Syringe Pack Brochure (PDF)

EDA*
Unique patented EDA provides additional patient safety and peace of mind for the technologist. It detects, notifies, and pauses procedures if clinically significant variation occurs, using a patented EDA patch.
Download the EDA Brochure (PDF)

eGFR Calculator
Assists in the critical evaluation of kidney function before contrast is delivered, simplifying calculations for added patient safety.

*EDA is designed to aid in the detection of extravasations and is not intended as a substitute for proper patient monitoring and good clinical practice.
EDA is a trademark of Bracco Injeneering S.A.

Colorado’s Poudre Valley Health System is rated one of the Top 15 Healthcare Systems in the U.S. Some of the Poudre Valley specialists share their thoughts about the innovative performance and safety features of the EmpowerCTA Injector System.

Stanley Weinstein, a Poudre Valley Hospital Radiologist, highlights some of the advanced safety features of the EmpowerCTA Injector System that revolutionize workflow and provide another level of reassurance during CT procedures. (1:02)

Jack Retzlaff - Director of Radiology Services - The Medical Center of the Rockies "Empower CTA…it’s everything we hoped it would be…In terms of cost, patient safety, and productivity, it’s a great win for the system." (1:02)

Liz Fegley - Director, Radiology, Medical Imaging - Poudre Valley Health System "There was great follow-through with every promise… we appreciate having Bracco on our team…" (0:16)

Kari Harkin - Team Leader, CT - Poudre Valley Health System
"It was much easier to learn than we thought it would be… now that we have the EmpowerCTA, we can’t imagine working any other way…" (0:25)

Melody Pierson - Manager, Radiology - Poudre Valley Health System
"We now have a method of accurately and easily tracking our data …" (1:04)

Thomas R. Dunphy - Radiologist - Poudre Valley Health System
"My first priority is patient safety, second is quality… Bracco has really stepped up and offered us a complete solution…" (1:02)

DUKE UNIVERSITY MEDICAL CENTER’S EXPERIENCE WITH EXTRAVASATON DETECTION ACCESSORY (EDA) TECHNOLOGY

Researchers at Duke University Medical Center collected and reviewed data over a 15-month period using the EmpowerCTA Injector System for radiology, emergency, and outpatient care services.

Some of the clinical guidelines for EDA use during the study included:

  • Use EDA on patients whose contrast injection IV site is likely to remain relatively stable during the procedure
  • Ensure a stable baseline acquisition on the remote display while applying the EDA sensing patch
  • Co-monitor IV access for the duration of the injection, including smart prep and “count down” time at the start of the injection

University researchers concluded that using EDA provided a number of important benefits for both patients and staff, including:

  • CT staff recognizing the value of EDA as a tool for improving clinical outcomes
  • Minimizing contrast media (vesicant) extravasation and resulting skin damage
  • Maximizing the CT staff's ability to complete important diagnostic imaging procedures
  • Quickly ruling out the presence of an extravasation so department workflow can continue without interruption

For more information about the study and its findings, read the full text of the whitepaper here:
A Retrospective Review: Duke University Medical Center's Experience With the Extravasation Detection Accessory Technology by Donna Parker, RT, co-director, Duke CT Institute.

EDA is a trademark of Bracco Injeneering S.A.

CLINICAL APPLICATIONS SPECIALISTS

Getting you started and keeping you going.

Experienced Bracco Diagnostics Inc. specialists are always available to provide all the support you need at installation and beyond. These highly trained professionals provide:

  • Staff training
  • Initial start-up and case oversight
  • Ongoing monthly and as-needed visits
  • On-call support
  • CEU programs

For more information and to schedule an appointment with a specialist, contact:
Ken Bodle, Manager, Device Operations
Phone: 760-881-0449 Email: kenneth.bodle@diag.bracco.com
259 Prospect Plains Road, Bldg. H Monroe Township, NJ 08831 USA

PROFESSIONAL SERVICES
For answers to your scientific and clinical questions about our products, please call 1-800-257-5181, Option 2, or email services.professional@diag.bracco.com.

EDUCATION AND TRAINING
Robust continuing medical education programs are available to help keep you abreast of developments across all imaging modalities.

CLINICAL TRIALS PROGRAMS
Bracco clinical trials programs further knowledge and fuel innovation in imaging. If you are interested in learning about our research, please contact us.

HEALTH CARE ECONOMICS
At Bracco, we take an active role in helping to secure reimbursement for contrast-enhanced procedures and advocating for continued improvement in efficiency, safety, and best practices.

CUSTOMER SERVICE
We support our customers with outstanding service. When we say it's all about you, we really mean it. Customer Service Specialists are always available to address your immediate and long-term needs, whatever they may be. All it takes is one call to our customer support center, and you'll be well on your way to receiving the information, assistance, or support that you require.

For Customer Service call: 877-BRACCO 9 (877-272-2269).

RESP product logo

Find your local rep

Contacts

Customer Service

1-877-272-2269

Drug Safety

1-800-257-5181, Option 1

Professional Services

1-800-257-5181, Option 2

Email: empowerinfo@diag.bracco.com

Indications and Usage

INDICATIONS:
The EmpowerCTA®+ Injector System is indicated for the vascular administration of contrast and flushing media in conjunction with computed tomography (CT) scanning of the body with an optional interface to a CT scanner and an optional calculator for glomerular filtration rate (GFR).

The Extravasation Detection Accessory (EDATM) is an optional accessory and is indicated for the detection of extravasations of ionic and nonionic contrast during CT procedures using a power injector.

CONTRAINDICATIONS:
The EmpowerCTA+ Injector System is not intended for use as a long-term infusion pump, nor is it intended to be used to inject any agents other than contrast or flushing media. Do not attempt to use the Injector for any other purpose (such as chemotherapy or drug infusion). The EmpowerCTA+ Injector System should not be used to inject substances into nonvascular body cavities. Any applications of the EmpowerCTA+ Injector System other than those described in its Operator Manual are inappropriate and should not be attempted.

Protocols have been independently developed and are not intended as medical advice. Bracco and Bracco Injeneering S.A. shall not be responsible for any physicians’ reliance on these or any other products.

Not all products available in all global markets.

EmpowerCTA+ is distributed by Bracco Diagnostics Inc., 259 Prospect Plains Road, Bldg. H, Monroe Township, NJ 08831 USA; Phone: (800) 631-5245; Fax: (609) 514-2424.

EmpowerCTA+ is manufactured by Bracco Injeneering S.A., Avenue de Sevelin 46, CH–1004 Lausanne, Switzerland. http://imaging.bracco.com

Customer Service: 1-877-BRACCO 9 (1-877-272-2269)
Professional Services: 1-800-257-5181, Option 2
EmpowerCTA+ Email: empowerinfo@diag.bracco.com

About Bracco Injeneering S.A.
Bracco Injeneering S.A., located in Lausanne, Switzerland, is the most recently added Business Unit of Bracco Imaging. Bracco Injeneering is committed to develop the best-in-class integrated injection solutions with a strong heritage in research and innovation. It provides quality solutions for state-of-the-art radiology centers, offering proven injection technology, built on Bracco Imaging’s expertise.

Thanks to this strengthened product portfolio, including the CT Exprès® 3D Contrast Media Delivery System, EmpowerCTA+ Injector System, EmpowerMR® Injector System, NEXO® Contrast Management System and NEXO [DOSE]® Multi-Modality Radiation Informatics, Bracco Imaging will be able to focus on constant innovation, not only for devices, but also for software development and data management.

CT Exprès, EmpowerCTA, IRiSCT, EmpowerMR, EmpowerSync, NEXO and NEXO [DOSE] are registered trademarks of Bracco Injeneering S.A.

EDA is a trademark of Bracco Injeneering S.A.